Nutanix stock falls as early results top expectations

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 49 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 97%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Nutanix Inc. shares rose then fell in the extended session Monday after the hyperconverged-infrastructure company topped expectations with preliminary...

Nutanix Inc.

shares rose then fell in the extended session Monday after the hyperconverged-infrastructure company topped expectations with preliminary results. Nutanix shares rose as much as 6% after hours, then fell 3%, following a 0.5% rise in the regular session to close at $28.77. The company said that preliminary second-quarter revenue rose to $486.5 million from $413.1 million in the year-ago quarter, and annual contract value, or ACV, billings rose to $267.6 million from $217.

shares rose then fell in the extended session Monday after the hyperconverged-infrastructure company topped expectations with preliminary results. Nutanix shares rose as much as 6% after hours, then fell 3%, following a 0.5% rise in the regular session to close at $28.77. The company said that preliminary second-quarter revenue rose to $486.5 million from $413.1 million in the year-ago quarter, and annual contract value, or ACV, billings rose to $267.6 million from $217.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trialsShares of BioMarin Pharmaceutical Inc. were down about 6.0% in premarket trading on Monday after BridgeBio Pharma Inc. shared positive Phase 2 clinical data...
Source: MarketWatch - 🏆 3. / 97 Read more »

Proxy advisors urge shareholders to reject Ritchie Bros bid for IAAProxy advisory firms Institutional Shareholder Services and Glass Lewis on Monday recommended that shareholders reject Ritchie Brothers Auctioneers Inc's planned $7 billion acquisition of U.S. auto retailer IAA Inc .
Source: Reuters - 🏆 2. / 97 Read more »

5 things to know before the stock market opens MondayHere are the most important news items that investors need to start their trading day.
Source: CNBC - 🏆 12. / 72 Read more »